Rolf Billeskov

1.7k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Rolf Billeskov is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rolf Billeskov has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Rolf Billeskov's work include Tuberculosis Research and Epidemiology (12 papers), Immunotherapy and Immune Responses (10 papers) and vaccines and immunoinformatics approaches (6 papers). Rolf Billeskov is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Immunotherapy and Immune Responses (10 papers) and vaccines and immunoinformatics approaches (6 papers). Rolf Billeskov collaborates with scholars based in Denmark, United States and Spain. Rolf Billeskov's co-authors include Peter Andersen, Jes Dietrich, Claus Aagaard, Truc Thi Kim Thanh Hoang, Angelo Izzo, Joseph P. Cassidy, Père-Joan Cardona, Gary K. Schoolnik, Gregory Dolganov and Jay A. Berzofsky and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Rolf Billeskov

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multistage tuberculosis vaccine that confers efficient protection before and after exposure

2011 444 citations Claus Aagaard, Truc Thi Kim Thanh Hoang et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolf Billeskov Denmark	19	897	882	526	374	94	22	1.4k
Hillarie Plessner Windish United States	13	475 0.5×	782 0.9×	409 0.8×	363 1.0×	44 0.5×	15	1.2k
Daniela Damjanovic Canada	19	522 0.6×	913 1.0×	503 1.0×	315 0.8×	46 0.5×	26	1.5k
Matteo Bianchi Switzerland	10	275 0.3×	716 0.8×	334 0.6×	395 1.1×	40 0.4×	16	1.2k
J Iványi United Kingdom	18	529 0.6×	399 0.5×	513 1.0×	496 1.3×	129 1.4×	44	1.2k
Corine Prins Netherlands	16	1.0k 1.2×	675 0.8×	679 1.3×	372 1.0×	306 3.3×	27	1.5k
Venetta Thomas United States	16	534 0.6×	641 0.7×	165 0.3×	265 0.7×	18 0.2×	24	1.5k
Lakshmi Ramachandra United States	18	282 0.3×	609 0.7×	265 0.5×	347 0.9×	46 0.5×	28	1.0k
Yoichi Furuya United States	17	220 0.2×	395 0.4×	459 0.9×	171 0.5×	69 0.7×	46	935
Xiao-Ning Xu United Kingdom	7	676 0.8×	853 1.0×	679 1.3×	371 1.0×	19 0.2×	7	1.7k
Keiko Fujihashi United States	18	163 0.2×	884 1.0×	243 0.5×	168 0.4×	71 0.8×	31	1.3k

Countries citing papers authored by Rolf Billeskov

Since Specialization

Citations

This map shows the geographic impact of Rolf Billeskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Billeskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Billeskov more than expected).

Fields of papers citing papers by Rolf Billeskov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Billeskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Billeskov. The network helps show where Rolf Billeskov may publish in the future.

Co-authorship network of co-authors of Rolf Billeskov

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Billeskov. A scholar is included among the top collaborators of Rolf Billeskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Billeskov. Rolf Billeskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benčina, Goran, et al.. (2024). Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort. SHILAP Revista de lepidopterología. 5(8). 905–912. 2 indexed citations

Knudsen, Niels Peter Hell, Rolf Billeskov, Ida Rosenkrands, et al.. (2020). Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection. Frontiers in Immunology. 11. 585359–585359. 18 indexed citations

Billeskov, Rolf, et al.. (2018). The effect of antigen dose on T cell-targeting vaccine outcome. Human Vaccines & Immunotherapeutics. 15(2). 407–411. 45 indexed citations

Billeskov, Rolf, Thomas Lindenstrøm, Joshua S. Woodworth, et al.. (2018). High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis. Frontiers in Immunology. 8. 1973–1973. 31 indexed citations

Sui, Yongjun, Blake Frey, Yichuan Wang, et al.. (2017). Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques. PLoS Pathogens. 13(5). e1006395–e1006395. 20 indexed citations

Billeskov, Rolf, Yichuan Wang, Shahram Solaymani-Mohammadi, et al.. (2017). Low antigen dose in adjuvant-based vaccination selectively induces CD4 T cells with enhanced functional avidity and protective efficacy. The Journal of Immunology. 198(Supplement_1). 73.9–73.9. 1 indexed citations

Billeskov, Rolf, Esterlina V. Tan, Rodolfo M. Abalos, et al.. (2016). Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis. PLoS ONE. 11(8). e0161217–e0161217. 28 indexed citations

Knudsen, Niels Peter Hell, Anja Weinreich Olsen, Cecilia Buonsanti, et al.. (2016). Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens. Scientific Reports. 6(1). 19570–19570. 183 indexed citations

Solaymani-Mohammadi, Shahram, Omar Lakhdari, Steve Shenouda, et al.. (2015). Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules. Journal of Leukocyte Biology. 99(3). 475–482. 20 indexed citations

10.

Billeskov, Rolf, Jan Pravsgaard Christensen, Claus Aagaard, Peter Andersen, & Jes Dietrich. (2013). Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-Human Primate Tuberculosis Model. PLoS ONE. 8(8). e72185–e72185. 28 indexed citations

11.

Billeskov, Rolf, et al.. (2012). The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity. PLoS ONE. 7(6). e39909–e39909. 80 indexed citations

12.

Aagaard, Claus, Truc Thi Kim Thanh Hoang, Jes Dietrich, et al.. (2011). A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nature Medicine. 17(2). 189–194. 444 indexed citations breakdown →

13.

Billeskov, Rolf, Michael V. Grandal, Christian Poulsen, et al.. (2010). Difference in TB10.4 T‐cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis. European Journal of Immunology. 40(5). 1342–1354. 18 indexed citations

14.

Aagaard, Claus, Truc Thi Kim Thanh Hoang, Angelo Izzo, et al.. (2009). Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose. PLoS ONE. 4(6). e5930–e5930. 128 indexed citations

15.

Hoang, Truc Thi Kim Thanh, Anneline Nansen, Sugata Roy, et al.. (2009). Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis. PLoS ONE. 4(6). e5928–e5928. 25 indexed citations

16.

Christensen, Jan Pravsgaard, Rolf Billeskov, Truc Thi Kim Thanh Hoang, et al.. (2009). CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination. PLoS ONE. 4(4). e5139–e5139. 58 indexed citations

17.

Billeskov, Rolf, Carina Vingsbo Lundberg, Peter Andersen, & Jes Dietrich. (2007). Induction of CD8 T Cells against a Novel Epitope in TB10.4: Correlation with Mycobacterial Virulence and the Presence of a Functional Region of Difference-1. The Journal of Immunology. 179(6). 3973–3981. 85 indexed citations

18.

Dietrich, Jes, Rolf Billeskov, T. Mark Doherty, & Peter Andersen. (2007). Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection. The Journal of Immunology. 178(6). 3721–3730. 51 indexed citations

19.

Doherty, T. Mark, Jes Dietrich, & Rolf Billeskov. (2007). Tuberculosis subunit vaccines: from basic science to clinical testing. Expert Opinion on Biological Therapy. 7(10). 1539–1549. 22 indexed citations

20.

Billeskov, Rolf, et al.. (2006). Hippocampal neuron and glial cell numbers in Parkinson's disease—A stereological study. Hippocampus. 16(10). 826–833. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact